Tudor Investment Corp’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,124
Closed -$76K 2491
2021
Q4
$76K Sell
3,124
-27
-0.9% -$904 ﹤0.01% 2245
2021
Q3
$142K Buy
3,151
+7
+0.2% +$294 ﹤0.01% 2343
2021
Q2
$147K Buy
3,144
+246
+8% +$12.6K ﹤0.01% 1514
2021
Q1
$160K Buy
+2,898
New +$176K ﹤0.01% 1459
2020
Q4
Sell
-5,326
Closed -$312K 1547
2020
Q3
$312K Buy
+5,326
New +$394K 0.01% 969
2018
Q3
Sell
-542
Closed -$227K 1201
2018
Q2
$227K Buy
+542
New +$183K 0.01% 893

Other funds holding OPTN

Tudor Investment Corp's OPTN Position: Q1 2022 in Review

Tudor Investment Corp sold out of OptiNose (OPTN) in Q1 2022, closing a stake of 3,124 shares — an estimated $76K sold.

Tudor Investment Corp first reported a position in OPTN in Q2 2018 and held it in 6 quarters. The position peaked at $312K in Q3 2020. 44 funds tracked by Wall St. Rank hold OPTN as of Q1 2022.

  • Tudor Investment Corp reported no remaining OptiNose position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 3,124 OptiNose shares in Q1 2022, an estimated $76K.
  • Tudor Investment Corp first reported a position in OptiNose in Q2 2018 and held it in 6 quarters.
  • Tudor Investment Corp's OptiNose position peaked at $312K in Q3 2020.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.